• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因骨髓移植治疗T原淋巴细胞白血病。

Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.

作者信息

Collins R H, Piñeiro L A, Agura E D, Fay J W

机构信息

Bone Marrow Transplantation, Baylor University Medical Center/Texas Oncology, Dallas 75246, USA.

出版信息

Bone Marrow Transplant. 1998 Mar;21(6):627-8. doi: 10.1038/sj.bmt.1701127.

DOI:10.1038/sj.bmt.1701127
PMID:9580345
Abstract

T prolymphocytic leukemia (T-PLL) is an unusual disease characterized by high white cell counts, older age at presentation, splenomegaly and a very aggressive clinical course. We describe a 47-year-old male with refractory T-PLL who was treated with high-dose chemoradiotherapy and allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling. The transplant was complicated by both acute and chronic graft-versus-host disease (GVHD). The patient achieved complete remission and remains in remission 3 years after the transplant.

摘要

T 细胞幼淋巴细胞白血病(T-PLL)是一种罕见疾病,其特征为白细胞计数高、发病时年龄较大、脾肿大以及临床病程极为凶险。我们描述了一名 47 岁难治性 T-PLL 男性患者,他接受了大剂量放化疗以及来自 HLA 匹配同胞的异基因骨髓移植(BMT)。移植过程并发了急性和慢性移植物抗宿主病(GVHD)。患者实现了完全缓解,移植后 3 年仍处于缓解状态。

相似文献

1
Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation.异基因骨髓移植治疗T原淋巴细胞白血病。
Bone Marrow Transplant. 1998 Mar;21(6):627-8. doi: 10.1038/sj.bmt.1701127.
2
Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.异基因骨髓移植后发生急性移植物抗宿主病时慢性淋巴细胞白血病和幼淋巴细胞白血病的临床及血液学反应:移植物抗白血病的可能作用
Bone Marrow Transplant. 1996 Mar;17(3):371-5.
3
[Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].[异基因骨髓移植治疗化疗耐药性T-原淋巴细胞白血病]
Rinsho Ketsueki. 2005 Jul;46(7):527-31.
4
Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement.一名患有伴有小肠受累的T-原淋巴细胞白血病患者接受异基因骨髓移植。
Int J Clin Oncol. 2003 Dec;8(6):391-4. doi: 10.1007/s10147-003-0349-1.
5
Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease.原发性难治性幼淋巴细胞白血病采用减低剂量预处理的异基因外周血干细胞移植:移植物抗白血病效应且无移植物抗宿主病
Bone Marrow Transplant. 2001 Dec;28(12):1155-6. doi: 10.1038/sj.bmt.1703309.
6
[Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
Rinsho Ketsueki. 2004 Sep;45(9):1044-7.
7
Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.通过去除骨髓移植物中的CD4+淋巴细胞并减少CD8+淋巴细胞来预防高危患者的移植物抗宿主病。
Bone Marrow Transplant. 1999 Mar;23(5):443-50. doi: 10.1038/sj.bmt.1701493.
8
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remission.低强度预处理后异基因干细胞移植治疗T细胞幼淋巴细胞白血病患者:移植物抗肿瘤效应与长期缓解
Bone Marrow Transplant. 2006 Apr;37(7):709-10. doi: 10.1038/sj.bmt.1705294.
9
Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.输注的CD34+细胞剂量可预测首次完全缓解时接受来自匹配同胞供体的异基因骨髓移植的急性髓性白血病患者的长期生存情况。
Biol Blood Marrow Transplant. 2005 Feb;11(2):122-8. doi: 10.1016/j.bbmt.2004.11.018.
10
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.异基因反应性以及抗受体特异性产生白细胞介素2的辅助性T淋巴细胞前体细胞频率对骨髓移植后异基因反应性的预测价值。
Dan Med Bull. 2002 May;49(2):89-108.

引用本文的文献

1
Advances in Cellular Therapy for T-Cell Prolymphocytic Leukemia.T 细胞幼淋巴细胞白血病细胞疗法的进展
Front Oncol. 2022 Feb 11;12:781479. doi: 10.3389/fonc.2022.781479. eCollection 2022.
2
T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India.T 细胞幼淋巴细胞白血病:来自印度南部一家三级癌症中心的经验。
Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):132-135.
3
Advances in the understanding and management of T-cell prolymphocytic leukemia.T细胞幼淋巴细胞白血病的认识与治疗进展
Oncotarget. 2017 Nov 1;8(61):104664-104686. doi: 10.18632/oncotarget.22272. eCollection 2017 Nov 28.
4
A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.一名白细胞计数超过一百万的患者:诊断与治疗挑战
Bisturi (S Juan). 2016 Mar-Jun;2016:12-16.
5
T-cell prolymphocytic leukaemia (T-PLL): a rare disease with a grave prognosis.T细胞幼淋巴细胞白血病(T-PLL):一种预后严重的罕见疾病。
BMJ Case Rep. 2013 May 2;2013:bcr2013009808. doi: 10.1136/bcr-2013-009808.
6
Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.异基因造血细胞移植治疗幼淋巴细胞白血病。
Biol Blood Marrow Transplant. 2010 Apr;16(4):543-7. doi: 10.1016/j.bbmt.2009.11.021. Epub 2009 Dec 2.
7
Peripheral T-cell lymphoma.外周T细胞淋巴瘤
Curr Oncol Rep. 2002 Sep;4(5):434-42. doi: 10.1007/s11912-002-0038-7.
8
Management of chronic lymphocytic leukaemia.慢性淋巴细胞白血病的管理
Drugs Aging. 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002.